Travelers EVP Michael Klein sells $2.2m in company stock By Investing.com

Michael Frederick Klein, Executive Vice President and President of Personal Insurance at The Travelers Companies, Inc. (), sold 6,000 shares of company common stock on July 21, 2026, for a total value of approximately $2.2 million.

The sales occurred in two separate transactions. Mr. Klein disposed of 125 shares at a weighted average price of $364.9033 per share, with individual sale prices ranging from $364.72 to $365.03. An additional 5,875 shares were sold at a weighted average price of $366.1189 per share, with prices ranging from $365.798 to $366.275. The timing of the sale comes as Travelers stock trades near its 52-week high of $378.66, with shares currently at $376.37. The stock has delivered a 46% return over the past year. According to InvestingPro analysis, Travelers appears overvalued at current levels. InvestingPro offers 15 additional exclusive tips for TRV subscribers.

Prior to these sales on the same day, Mr. Klein acquired 6,000 shares of Travelers common stock by exercising stock options at an exercise price of $139.83 per share, totaling $838,980. These options were exercisable as of February 2, 2024, and are set to expire on February 2, 2031.

Following these transactions, Mr. Klein directly holds 45,124.787 shares of Travelers common stock. He also indirectly holds 1,895.088 shares through a 401(k) Plan. Additionally, Mr. Klein beneficially owns 30,037 derivative securities in the form of stock options.

In other recent news, Travelers Companies Inc. reported strong second-quarter earnings, surpassing estimates from several analysts. BofA Securities noted that Travelers’ earnings exceeded their estimate of $5.45 per share and the Street consensus of $5.37 per share, highlighting a favorable reserve development. Following these results, several firms adjusted their outlooks for the company. Truist Securities raised its price target to $425, citing earnings momentum and increasing its full-year 2026 earnings per share estimate to $34.10. Similarly, Raymond James increased its price target to $430, maintaining a Strong Buy rating, and emphasized the company’s profitability outlook. Keefe, Bruyette & Woods also raised its price target to $373 and increased earnings estimates for 2026 and 2027. Despite these positive assessments, Goldman Sachs downgraded the stock to Sell, setting a price target of $350, due to concerns about valuation. These developments reflect a varied analyst outlook on Travelers Companies Inc., with some focusing on earnings strength and others expressing caution about valuation.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.